medigraphic.com

2014, Number 4

<< Back Next >>

Cir Cir 2014; 82 (4)

Intrathoracic-mediastinal myofibroblastic tumor. Report and experience of one case

Hernández-Ascencio JA, Rios-Cruz D, Grube-Pagola P, Gómez-Calzada JG

Language: Spanish
References: 21
Page: 412-417
PDF size: 503.65 Kb.


ABSTRACT

Background: Inflammatory pseudotumor is a little known and uncommon condition. The debate continues whether it represents an inflammatory lesion or is a true neoplasm. It is considered a reactive process usually characterized by irregular growth of inflammatory cells. It has been described at various sites, the most common being the lung. The aim of this report is to emphasize the difficulty in the initial diagnosis.
Clinical case: We present the case of a 56-year-old male who reports an 8-month history of dry cough, dyspnea, fatigue, weakness and weight loss of 20 kg. We performed two biopsies, one positive for malignancy without response to medical treatment and the second reporting chronic granulomatous inflammation. The patient underwent sternotomy, revealing a tumor of 20 × 17 × 10 cm, weighing ~2 kg. The tumor was dependent on the anterior mediastinum surrounding large vessels, and venous brachiocephalic, pericardium and both pleuras with firm adhesions to the right lung. Pathological report was as follows: inflammatory myofibroblastic tumor with positive immunohistochemistry for CD20 and CD3. Postoperative course was satisfactory and 1 year after surgery there was no evidence of recurrence.
Conclusion: Inflammatory pseudotumor is a benign neoplasm of unknown origin with a chronic course. It can simulate a malignant tumor, causing constitutional manifestations, airway obstruction, cardiac alterations or other symptoms according to their location. Diagnosis is based on radiological features and direct biopsy. Treatment of choice is complete resection of the tumor with a favorable long-term outcome.


REFERENCES

  1. Mondello B, Lentini S, Barone M, Barresi P, Monaco F, Familiari D, et al. Surgical management of pulmonary inflammatory psudotumors: A single center experience. J Cardiothoracic Surg 2011;6:18-23.

  2. Fornell-Pérez R, Santana-Montesdeoca JM, Garcia-Villar C, Camacho-Garcia MC. Dos formas de presentación del seudotumor inflamatorio pulmonar. Arch Bronconeumol 2012;48(8):296-299.

  3. Biselli R, Ferlini C, Fattorosi A, Boldrini R, Bosman C. Inflammatory myofibroblastic tumor (Inflammatory pseudotumor): DNA flow cytometric analysis of nine pediatric cases. Cancer 1996;77(4):778-784.

  4. Yamaguchi M, Yoshiro I, Osoegawa A, Toshifumi K, Tagawa T, Fukuyama S, et al. Inflammatory myofibroblastic tumor of the mediastinum presenting as superior vena cava síndrome. J Thorac Cardiovasc Surg 2003;126:870-872.

  5. Fabre D, Fadel E, Singhal S, Montpreville V, Mussot S, Mercier O, et al. Complete resection of pulmonary inflammatory pseudotumors has excellent lon-term prognosis. J Thorac Cardiovasc Surg 2009;137(2):435-440.

  6. Snyder C, Dell´Aquila M, Haghighi P, Baergen R, Suh Y, Yi ES. Clonal changes in inflammatory pseudotumor of the lung. A case report. Cancer 1995;76(9):1545-1549.

  7. Gal AA, Koss MN, McCarthy WF, Hochholzer L. Prognostic factors in pulmonary fibrohisticytic lesions. Cancer 1994;73(7):1817-1824.

  8. Melloni G, Carreta A, Ciriaco P, Arrigoni G, Fieschi S, Rizzo N, et al. Inflammatory Pseudotumor of the Lung in Adults. Ann Thorac Surg 2005;79(2):426-432.

  9. Pettinato G, Manivel JC, De Rosa N, Dehner LP. Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol 1990;94(5):538-546.

  10. Agrons GA, Rosado-de-Christenson ML, Kirejczyk WM, Conran RM, Stocker JT. Pulmonary inflammatory pseudotumor: radiologic features. Radiology 1998;206(2):511-518.

  11. Cerfolio RJ, Allen MS, Nascimento AG, Deschamps C, Trastek VF, Miller DL, et al. Inflammatory pseudotumors of the lung. Ann Thorac Surg 1999;67(4):933-936.

  12. Gómez-Román JJ, Sánchez-Velasco P, Ocejo-Vinyals G, Hernández-Nieto E, Leyva-Cobián F, Val-Bernal JF. Human Herpesvirus-8 Genes Are Expressed in Pulmonary Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor). Am J Surg Pathol 2001;25(5):624-629.

  13. Berman M, Georgios GP, Schonfeld T, Feinmesser M, Horev G, Vidne BA, et al. Pulmonary inflammatory myofibroblastic tumorinvading the left atrium. Ann Thorac Surg 2003;76(2):601-603.

  14. Maier HC, Sommers SC. Recurrent and metastatic pulmonary fibrous histiocytoma/plasma cell granuloma in child. Cancer 1987;60(5):1073-1076.

  15. Pinilla I, Herrero Y, Torres MI, Nistal M, Pardo M. Tumor inflamatorio miofibroblástico pulmonar. Radiología 2007;49(1):53-55.

  16. Matsubara O, Tan-Liu NS, Kenney RM, Mark EJ. Inflammatory pseudotumors of the lung: Progression from organizing pneumonia to fibrous histiocytoma or to plasma cell granulomas in 32 cases. Hum Pathol 1988;19(7):807- 814.

  17. Colby TV, Koss MN, Travis WD. Tumors of the Lower Respiratory Tract Washington DC: Armed Forced Institue of Pathology 1995;327-352.

  18. Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumor. En: Fletcher CDM, Unni KK, Mertens F, editores. World Health Organization classification of tumor: Pathology and genetics, tumor of soft tissue and bone. Lyon, France: IARC Press, 2002. p. 91-93.

  19. Loeffler-Ragg J, Bodner J, Freund M, Steurer M, Uprimny C Zelger B, et al. Diagnostic and therapeutic challenges of a large pleural inflammatory myofibroblastic tumor. Case Rep Pulmonol. 2012;2012:102196. Disponible en http:// www.hindawi.com/crim/pulmonology/2012/102196/.

  20. Bando T, Fujimura M, Noda Y, Hirose J, Ohta G, Matsuda T. Pulmonary plasma cell granuloma improves with corticosteroid therapy. Chest 1994;105(5):1574-1575.

  21. Shirakusa T, Kusano T, Motonaga R, Eimoto T. Plasma Cell Granuloma of the Lung - Resection and Steroid Therapy. Thorac Cardiovasc Surg 1987;35(3):185-188.




2020     |     www.medigraphic.com